Dr Serena Seah Bee Kee

Selected Publications

• Wang T, Seah S, Loh X, Chan CW, Hartman M, Goh BC, Lee SC.
  Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signaling are reversed by metabolic products of the mevalonate pathway. Oncotarget. 2016 Jan 19;7(3):2532-44
  
• Seah S, Low IC, Hirpara JL, Sachaphibulkij K, Kroemer G, Brenner C, Pervaiz S
  Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells. Cell Death Dis. 2015 Oct 22;6: e1926.
  
• Subramaniam MM, Ng SB, Seah SB, Anuar D, Soong R, Lee VK.
  Molecular characterization of dedifferentiated mucoepidermoid carcinoma of the trachea using laser microdissection-based TP53 mutation analysis. Histopathology. (2009)Oct;55(4):472-5
  
• Wong AS, Soong R, Seah SB, Lim SW, Chuah KL, Nga ME, Chin TM, Soo RA
  Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer. J Thorac Oncol. (2008) Apr;3(4):400-4.
  
• Melamed P., Abdul Kadir.M.N., Wijeweera A., Seah S.
  Transcription of gonadotropin β subunit genes involves cross-talk between the transcription factors and co-regulators that mediate actions of the regulatory hormones. Mol. Cell. Endocrinol. (2006) Vol. 252, 167-18